JPMorgan's top biotech and pharma picks for the second half
Biopharmaceutical stocks' underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm's June outlook for biopharma that the sector's poor performance can be traced back to concerns over President Donald Trump's tariffs and his " most favored nation " executive order. The SPDR S & P Biotech ETF (XBI) has pulled back about 7% so far in 2025, while the S & P 500 has notched a nearly 2% gain. The stock action is overdone, according to Schott, as he expects any impact from this policy will be "manageable." Valuations are historically depressed, Schott said, which means the sector has already priced in the the worst possible outcome. "The sector [should be] able to largely mitigate the impact of tariffs in the mid/long term through manufacturing repatriation and 2) [there's] no clear path for MFN ["most favored nation"] to move forward without Congressional approval (outside of IRA price negotiations)," Schott said. Fundamentals for biopharma stocks have improved in recent years, which should support "a more manageable sales/EPS erosion outlook for most names," he added. Here's a look at some of JPMorgan's favorite biotech and pharma stocks heading into the second half of the year. All stocks on the list are rated overweight by the firm. Eli Lilly stock is among JPMorgan's top picks among the group. Shares are about flat in 2025, and have slipped roughly 8% over the past 12 months. The company agreed to purchase SiteOne Therapeutics in a roughly $1 billion deal last week , which could allow Lilly to develop non-opioid treatments for chronic pain conditions. LLY YTD mountain Eli Lilly stock in 2025. Developing non-opioid pain drugs is a key focus for the industry, with Vertex Pharmaceuticals recently approving its Journavx Nav1.8 inhibitor. About 84% of analysts polled by FactSet maintain a buy rating on Eli Lilly stock, with their consensus price target equating to nearly 29% upside. Gilead Sciences is also one of JPMorgan's top picks. Shares have soared more than 20% so far in 2025. GILD YTD mountain Gilead Sciences stock in 2025. Analysts surveyed by FactSet think the stock has more room to run after a strong first half of the year. Alongside a consensus buy rating, the average analyst price target calls for more than 5% upside. The company recently announced key phase three trial data tied to its Trodelvy cancer treatment that showed the drug lowered the risk of a severe form of breast cancer when used in combination with Merck 's Keytruda immunotherapy treatment. Other names on the list include Regeneron Pharmaceuticals and Bristol Myers Squibb .
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
28 minutes ago
- CNBC
Jobs, profit-taking and 2 other things that drove the stock market this week
The very public implosion of President Donald Trump and Elon Musk 's alliance may have captivated Wall Street this week, but the government's solid monthly employment report was the real showstopper. In addition to those two developments, earnings from Club names CrowdStrike and Broadcom , and the back-and-forth between Trump and Chinese President Xi Jinping on trade defined the market. 1. Jobs, stocks , Fed : The S & P 500 jumped 1% on Friday on the labor data , which showed job growth in May that was strong enough to ease fears of a recession and warmer-but-not-too-hot wage inflation. With both sides of the Federal Reserve's dual mandate of maximizing employment and fostering price stability in check, the market still felt comfortable rooting for an interest rate cut down the line. For the week, the S & P 500 rose 1.5% , logging its back-to-back weekly gains. For the second time this week, and despite Friday's solid nonfarm payrolls data, Trump prodded Fed Chairman Jerome Powell to cut rates – this time, calling for a full percentage point reduction . The market is predicting virtually no chance of a reduction at the central bank's upcoming meeting later this month. On Wednesday, the president called for a Fed rate cut after the weak ADP private sector hiring report. Powell has been saying all along that he won't be influenced by politics and will be economic data dependent. The Fed chief has also said he would like to see more data on whether Trump's tariffs, which are moving targets and not finalized, negatively impact the economy. 2. Scorched Earth : Could the relationship between the world's most powerful man, Trump, and the world's richest, Musk, end any other way than the way it did Thursday? Both billionaires went after each other on social media. Trump called Musk "crazy" and threatened to kill federal contracts with Musk's companies, including SpaceX. Musk called for Trump's impeachment, criticized Trump's "Big Beautiful Bill" of tax cuts and spending priorities making its way on Capitol Hill, and then said SpaceX would decommission its Dragon spacecraft. Musk later took back that last part. Tesla shares sank over 14% on Thursday – but on Friday, recovered more than 3.5%. Also on Friday, Trump said he was not interested in having a call with Musk. Putting all the drama aside, there are real issues at play here concern the federal budget deficit and the billions upon billions of dollars of stock market value that has been erased from Musk's Tesla . Shares have lost more than 25% year to date. 3. Back on, again : The other Washington-related saga that has implications for stocks is trade talks between the U.S. and China. Trump announced on Friday that U.S.-China trade talks will take place Monday in London. The news comes after Trump and Xi finally talked on the phone Thursday. Last month, high-level U.S. officials met with their Chinese counterparts in Geneva, Switzerland, where they each agreed to pause most of the triple-digit tariff rates on each other's imports. Before the Trump-Xi call, the U.S. president accused China of violating that agreement – to which the Chinese accused the U.S. of not adhering to the deal. Reuters reported on Friday that China granted licenses for rare earth elements to the top three U.S. automakers. Back in April, China, which dominates in rare earths, put export curbs on the resources, which are key to making many of our modern-day products. 4. Records, then selling : Both CrowdStrike and Broadcom saw their stocks finish at record closing highs ahead of this week's respective earnings reports, which led to selling. CRWD YTD mountain CrowdStrike YTD Shares of CrowdStrike hit its closing record of just under $489 on Tuesday. Then after the bell, the cybersecurity delivered a mostly solid quarter . The stock lost 5.8% on Wednesday. Good old profit-taking after a big run to all-time highs contributed to the selling, and so did concerns about mixed guidance and some noise around federal government inquiries into the company — though nothing has changed in our stance toward last July's massive IT outage and its dealings with software reseller Carahsoft. The outage was caused by a botched CrowdStrike software update. CEO George Kurtz appeared on "Mad Money" with Jim and defended his company in the probes , saying the company is cooperating with investigators. On earnings night, we raised our price target to $500 per share from $400 but kept our hold-equivalent 2 rating in recognition of this year's more than 35% gain in the stock. Shares were modestly higher on Thursday and Friday. AVGO YTD mountain Broadcom YTD Broadcom shares closed at a record high of $261 each Wednesday. Then, after Thursday's close, Broadcom delivered a strong quarter and upbeat comments about its key artificial intelligence business. There are no signs that demand for the company's custom AI chips, or "accelerators," and networking solutions will let up anytime soon. On the software side, Broadcom continues to make the most of its blockbuster VMware acquisition. But again, profit-takers swooped in during Friday's session and pushed the stock down 5%. On earnings night, we raised our price target on the stock to $290 per share from $230 but kept our 2 rating. During Friday's Morning Meeting, Jim did tell investors without a position in Broadcom that it would be a good time to buy, starting with a partial position then building it up over time. (Jim Cramer's Charitable Trust is long CRWD, AVGO. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Yahoo
37 minutes ago
- Yahoo
Crypto Currents: Strategy buys more bitcoin
As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter STRATEGY BUYS MORE BITCOIN: Strategy (MSTR) announced updates on Monday with respect to its at-the-market offering programs and bitcoin holdings. The company purchased 705 bitcoin during the period of May 26 to June 1 at an aggregate purchase price of $75.1M. Strategy now holds 580,955 bitcoin. TRUMP MEDIA FILES REGISTRATION STATEMENT FOR BITCOIN ETF: On Thursday, Trump Media and Technology Group (DJT) announced the filing with the U.S. Securities and Exchange Commission of the initial registration statement on Form S-1 for the Truth Social Bitcoin ETF. The ETF will hold bitcoin directly and offer its shares to investors, aiming to reflect bitcoin's price performance. will act as the ETF's exclusive bitcoin custodian, prime execution agent and liquidity provider. The launch of the Truth Social Bitcoin ETF is pending effectiveness of the Registration Statement as well as approval of a Form 19b-4 filing with the SEC. Upon launch, the Shares will be listed on NYSE Arca. Yorkville America Digital acts as the sponsor of the ETF. Additionally on Thursday, Trump Media announced it has filed a registration statement on form S-3 with the U.S. Securities and Exchange Commission related to debt and equity subscription agreements recently entered into with approximately fifty investors that yielded approximately $2.3B in total proceeds. The proceeds will be used for the company's creation of a bitcoin treasury and for general corporate purposes. In accordance with registration obligations in the previously-disclosed agreements, the Registration Statement seeks to register for resale by the investors approximately 56M shares of equity and 29M shares underlying convertible notes. Additionally, having recently become form S-3 eligible, Trump Media is taking the customary step of including within the Registration Statement a universal shelf. CEO Devin Nunes said, 'These activities will provide the company with the capital, assets, independence, flexibility, and security we need to fulfill our goals of rapid expansion, guaranteeing a wide array of ways to access the capital markets when it's most advantageous to do so. We're systematically putting in place all the elements we need to grow the company according to our plans, acquire crown jewel assets, and draw more customers and users into the patriot economy.' MAWSON INFRASTRUCTURE APPOINTS INTERIM CEO: In a Thursday regulatory filing, Mawson Infrastructure Group (MIGI) reported it had provided Rahul Mewawalla with notice that termination of his employment as CEO and President of the company for 'Cause', based on conduct specified in the notice, will be considered at a future meeting of the company's Board of Directors, at which the Board will determine whether his conduct constitutes Cause sufficient to terminate Mewawalla in accordance with the terms of his employment agreement. Mewawalla's employment agreement with the company provides for a cure period, which will end on June 14. On June 2, the Board determined to place Mewawalla on administrative leave from his position as CEO and President and appointed Kaliste Saloom to serve as Interim CEO. Saloom has served as General Counsel and Corporate Secretary since July 1, 2024. HUT 8 INITIATED WITH BUY: On Thursday, Roth Capital initiated coverage of Hut 8 (HUT) with a Buy rating and $25 price target. Hut 8 is transforming into a power-first digital infrastructure platform, with 1.0GW energized, 2.6GW under exclusivity, and long-term growth visibility from bitcoin hosting and high-performance computing colocation, the analyst said. The firm added three HPC sites position the company to benefit from artificial intelligence demand, offering 60%-plus adjusted EBITDA margins. The combination of highly visible colocation agreements in bitcoin and HPC provides Hut 8 a strategic advantage, leading to margin expansion and re-rating potential with strategic execution, contended Roth. ANALYST CALLS GAMESTOP, STRATEGY VALUATION DISPARITY 'BAFFLING': On Thursday, Wedbush reiterated an Underperform rating on GameStop (GME) with a $13.50 price target after the company last week disclosed that it purchased 4,710 bitcoin, 'following the MicroStrategy playbook.' However, Strategy currently trades 1.75-times its bitcoin holdings, while GameStop trades at 2.4-times cash value, suggesting that investors value GameStop's entry into bitcoin at the same premium they assign to Strategy shares, but value GameStop's core operations at $8 per share, the analyst said. The firm added that while it is likely GameStop will convert more of its cash into bitcoin, the disparity in valuation between company and Strategy 'is baffling.' Both companies provide bitcoin investors the ability to use margin to invest in crypto, but GameStop's holdings 'are literally 1% as great as MSTR's,' according to Wedbush. The firm believes GameStop's entry into the trading card business has delivered 'modest success,' but it sees no potential for a rebound in the company's core business. OTHER CRYPTO NEWS: Bitcoin Depot (BTM) price target raised to $6 from $5 at Northland Riot Platforms (RIOT) hires Jonathan Gibbs as Chief Data Center Officer Trump's USD1 (JPM) to offer clients financing against crypto ETFs World Liberty Financial reportedly sends cease-and-desist over memecoin CRYPTO STOCK PLAYS: Publicly traded companies in the space include Bit Digital (BTBT), Coinbase (COIN), Core Scientific (CORZ), Greenidge Generation (GREE), Mara Holdings (MARA), Strategy, Riot Platforms and TeraWulf (WULF). PRICE ACTION: As of time of writing, bitcoin dropped roughly 1% this week to $104,449 in U.S. dollars, according to CoinDesk. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on MSTR: Disclaimer & DisclosureReport an Issue Strategy Announces Underwriting Agreement with Barclays World Liberty Financial sends cease-and-desist over memecoin, Bloomberg reports GameStop and Strategy valuation disparity 'baffling,' says Wedbush Stablecoin Issuer Circle (CRCL) Soars 235% in Market Debut JPMorgan to offer clients financing against crypto ETFs, Bloomberg reports
Fox News
37 minutes ago
- Fox News
Artificial Intelligence Newsletter
This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.
